BIOMAT Database Logo BIOMAT Database Logo

[Relationship between factor XIII and gelation phenomenon (author's transl)]. 1977

H Hasegawa

UI MeSH Term Description Entries
D005176 Factor XIII A fibrin-stabilizing plasma enzyme (TRANSGLUTAMINASES) that is activated by THROMBIN and CALCIUM to form FACTOR XIIIA. It is important for stabilizing the formation of the fibrin polymer (clot) which culminates the coagulation cascade. Coagulation Factor XIII,Factor XIII Transamidase,Fibrin Stabilizing Factor,Fibrinase,Laki-Lorand Factor,Blood Coagulation Factor XIII,Factor 13,Factor Thirteen,Laki Lorand Factor,Factor XIII, Coagulation,Stabilizing Factor, Fibrin,Transamidase, Factor XIII,XIII, Coagulation Factor
D005340 Fibrinogen Plasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains (alpha, beta, gamma) held together by disulfide bonds. Fibrinogen clotting is a sol-gel change involving complex molecular arrangements: whereas fibrinogen is cleaved by thrombin to form polypeptides A and B, the proteolytic action of other enzymes yields different fibrinogen degradation products. Coagulation Factor I,Factor I,Blood Coagulation Factor I,gamma-Fibrinogen,Factor I, Coagulation,gamma Fibrinogen
D005782 Gels Colloids with a solid continuous phase and liquid as the dispersed phase; gels may be unstable when, due to temperature or other cause, the solid phase liquefies; the resulting colloid is called a sol.

Related Publications

H Hasegawa
[Wound healing and factor XIII (author's transl)].
December 1977, Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,
H Hasegawa
[A case of congenital factor XIII deficiency and acquired factor XIII deficiency (author's transl)].
April 1976, Rinsho byori. The Japanese journal of clinical pathology,
H Hasegawa
[Blood coagulation factor XIII and fibrin stabilization (author's transl)].
December 1975, Klinische Wochenschrift,
H Hasegawa
[Studies on the relationship between factor XIII activity and fibrin clot solubility test by urea and monochloroacetic acid (author's transl)].
December 1977, Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,
H Hasegawa
[Separation of factor VIII and factor XIII from human plasma (author's transl)].
April 1976, Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,
H Hasegawa
[Fibrin stabilization and factor XIII substitution in malignant tumors (author's transl)].
July 1977, Arzneimittel-Forschung,
H Hasegawa
[Studies on factor XIII during the perinatal period (author's transl)].
December 1977, Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,
H Hasegawa
[A clinical study of congenital factor XIII deficiency (author's transl)].
May 1977, [Rinsho ketsueki] The Japanese journal of clinical hematology,
H Hasegawa
[Activity of the fibrin stabilising factor (factor XIII) in anaemias and polycythaemias (author's transl)].
December 1973, Munchener medizinische Wochenschrift (1950),
H Hasegawa
[Factor XIII deficiency in adults with acute leukemia: results of a substitution therapy with factor XIII (author's transl)].
August 1977, Klinische Wochenschrift,
Copied contents to your clipboard!